Get in Touch
We welcome inquiries from venture capital firms, pharmaceutical partners, and research collaborators. If you’re interested in learning more about our groundbreaking technology or exploring strategic partnerships, please reach out.
Let’s collaborate to shape the future of precision immunotherapy.
